More than 95 per cent of HIV infections occur in developing countries.
Curable infectious diseases like chlamydia and gonorrhoea are often left untreated and contribute to a major disease burden, particularly among women and children. In these countries, infections like scabies and trachoma—which can be cured by a single dose of antibiotic—impact the health of entire communities. And while the availability of a vaccine has decreased the burden of hepatitis B in Australia, the cost of treatment remains prohibitive in the world’s poorest countries.
We work in low and middle income countries, particularly those in our region, to invent practical and meaningful solutions to defeat epidemics. We equip local researchers with the knowledge and tools they need to conduct world-class research in their own communities. We have longstanding research collaborations with teams in Thailand, Indonesia, Papua New Guinea, Myanmar, Cambodia, Solomon Islands and Fiji.
Our research with people living in low and middle income countries includes clinical trials, public health interventions, laboratory collaborations, large-scale cohort studies, behavioural research and capacity building.
Our programs that work in this area
- Biostatistics and Databases
- HIV Epidemiology and Prevention
- Immunovirology and Pathogenesis
- Infection Analytics
- Public Health Interventions
- Sexual Health
- Therapeutic and Vaccine Research
- Viral Hepatitis Clinical Research
- Viral Hepatitis Epidemiology and Prevention
- Viral Immunology Systems
 |
 |
